Guardian Pharmacy Services, Inc. (NYSE:GRDN) Director Sells $70,739,524.80 in Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) Director William E. Bindley sold 3,508,905 shares of the firm's stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $20.16, for a total transaction of $70,739,524.80. Following the transaction, the director now directly owns 2,591,271 shares in the company, valued at $52,240,023.36. This represents a 57.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Guardian Pharmacy Services Price Performance

Shares of GRDN stock traded up $0.12 on Monday, hitting $21.29. 249,308 shares of the company's stock were exchanged, compared to its average volume of 168,739. Guardian Pharmacy Services, Inc. has a 12 month low of $14.16 and a 12 month high of $26.91. The company has a 50 day moving average of $23.18 and a 200 day moving average of $22.01.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The firm had revenue of $329.31 million for the quarter, compared to the consensus estimate of $321.21 million. On average, sell-side analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Institutional Trading of Guardian Pharmacy Services

Hedge funds have recently added to or reduced their stakes in the stock. Nuveen Asset Management LLC increased its holdings in shares of Guardian Pharmacy Services by 2.9% during the fourth quarter. Nuveen Asset Management LLC now owns 547,140 shares of the company's stock worth $11,085,000 after buying an additional 15,550 shares in the last quarter. Charles Schwab Investment Management Inc. bought a new stake in Guardian Pharmacy Services during the 4th quarter worth $544,000. Rhumbline Advisers acquired a new position in Guardian Pharmacy Services in the 4th quarter worth about $149,000. Northern Trust Corp bought a new position in Guardian Pharmacy Services in the fourth quarter valued at about $1,479,000. Finally, New York State Common Retirement Fund raised its position in Guardian Pharmacy Services by 17.9% in the fourth quarter. New York State Common Retirement Fund now owns 278,548 shares of the company's stock valued at $5,643,000 after purchasing an additional 42,368 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on GRDN. Wall Street Zen cut Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Truist Financial reissued a "buy" rating and issued a $28.00 target price (up from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Finally, Raymond James set a $28.00 price target on shares of Guardian Pharmacy Services and gave the stock an "outperform" rating in a report on Wednesday, May 14th.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.